Literature DB >> 8243282

Prolactin receptor messenger ribonucleic acid expression in the ovary during the rat estrous cycle.

D L Clarke1, B J Arey, D I Linzer.   

Abstract

We have investigated the relative amounts and sites of synthesis during the rat estrous cycle of the two ovarian mRNAs encoding the long and short PRL receptors (PRL-R). Quantitative analysis has revealed that the mRNA encoding the short PRL-R is consistently present throughout the cycle in lower quantities than the long receptor mRNA. Both receptor mRNAs are at maximal levels during proestrus, decline to their lowest level of expression during estrus, then gradually rise in metestrus and diestrus. By in situ hybridization, both receptor mRNAs are present during early proestrus in corpora lutea, in the granulosa cell layers of large Graafian follicles, and in the interstitial cells closely associated with these follicles. The short PRL-R mRNA was detected at significant levels in the granulosa-derived cumulus oophorus and in the thecal cell region at this time, whereas the long PRL-R mRNA was only weakly expressed in these cell types. In contrast, the long PRL-R mRNA was present at higher levels, compared to the short receptor mRNA, in the granulosa cells of preantral follicles in the interior of the ovary. On late proestrus, the long PRL-R mRNA was found predominantly in the mural granulosa cells of large Graafian follicles and in corpora lutea, but by estrous morning this mRNA appeared to be mostly restricted to the corpora lutea. This distribution was maintained through estrous evening and metestrous morning. On diestrus, both mRNAs were present in some corpora lutea and in the granulosa cell layer in a subset of the larger Graafian follicles, but were detected at even higher levels in the interstitial cells surrounding these follicles; again, the long receptor mRNA appeared to be only weakly expressed in the thecal cell region of these follicles. These results indicate that the levels and locations of PRL-R mRNA expression in the ovary, and therefore, the potential responsiveness of the ovary to PRL, change throughout the reproductive cycle. Furthermore, the presence of both receptor mRNAs in several different ovarian cell types suggests that both of these receptor forms play important roles in PRL physiology in the ovary.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243282     DOI: 10.1210/endo.133.6.8243282

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Mammary gland development in prolactin receptor knockout mice.

Authors:  C J Ormandy; N Binart; P A Kelly
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 2.  The ovarian gonadotropin receptors in health and disease.

Authors:  Paul A Fowler; Ilpo T Huhtaniemi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

3.  Effect of chronic thyroid hormone treatment on cycling, ovulation, serum reproductive hormones and ovarian LH and prolactin receptors in rats.

Authors:  G A Jahn; G Moya; H Jammes; R R Rosato
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

4.  Two forms of the prolactin receptor messenger ribonucleic acid are Present in ovine fetal liver and adult ovary.

Authors:  R V Anthony; G W Smith; A Duong; S L Pratt; M F Smith
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

5.  Short term hypothyroidism affects ovarian function in the cycling rat.

Authors:  María Belén Hapon; Carlos Gamarra-Luques; Graciela A Jahn
Journal:  Reprod Biol Endocrinol       Date:  2010-02-11       Impact factor: 5.211

6.  Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.

Authors:  Julia Halperin; Y Sangeeta Devi; Sangeeta Y Devi; Shai Elizur; Carlos Stocco; Aurora Shehu; Diane Rebourcet; Terry G Unterman; Nancy D Leslie; Jamie Le; Nadine Binart; Geula Gibori
Journal:  Mol Endocrinol       Date:  2007-11-01

7.  Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.

Authors:  Patrick W B Derksen; Tanya M Braumuller; Eline van der Burg; Marten Hornsveld; Elly Mesman; Jelle Wesseling; Paul Krimpenfort; Jos Jonkers
Journal:  Dis Model Mech       Date:  2011-01-31       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.